Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ChondroColl
- Development stage
- Preclinical
- Lead developer
- SurgaColl Technologies
- Modality
- Hydrogel Systems → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems, Fragment-Derived Small Molecules → Multivalent & Scaffold-Based Small Molecules → Small Molecules
- Administration
- Surgical Implantation
01
Overview
ChondroColl is a bio-mimetic, three-layer regenerative scaffold developed by SurgaColl Technologies for the repair of articular joint cartilage. Composed of collagen, hydroxyapatite, and hyaluronic acid, the implant's architecture and composition are designed to mimic the natural structure of joint tissue. It works by stimulating the patient's own stem cells to migrate into the scaffold and differentiate, thereby regenerating both the cartilage and the underlying subchondral bone. Primarily indicated for early-stage cartilage damage in the knee, ChondroColl aims to provide a drug-free alternative to traditional surgical interventions, potentially delaying or preventing the onset of osteoarthritis and the need for total knee replacement.
- Brand names
- ChondroColl
Beyond the preview
Go deeper on ChondroColl.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ChondroColl.